Acrylamide not linked to breast cancer in US women, study finds

August 21, 2007

BOSTON, Aug. 21, 2007 -- Foods that contain acrylamide are unlikely to cause breast cancer in women, according to preliminary results of a new study involving 100,000 U.S. women. The finding, the largest epidemiological study to date exploring the possible link between acrylamide and cancer in humans, was described today at the 234th national meeting of the American Chemical Society.

"At levels consumed in the diet, it appears unlikely that acrylamide in foods is related to breast cancer risk," says study leader Lorelei Mucci, ScD, an epidemiologist at Channing Labs at Brigham and Women's Hospital and Harvard School of Public Health in Boston. In prior work, her group also examined dietary acrylamide and risk of cancer of the colon, rectum, bladder and kidney, and similarly found no association. "Although we do not rule out that very high levels of acrylamide could cause cancer, it appears that at the levels found in the diet, it is unlikely."

Acrylamide has been detected in many widely-consumed foods, ranging from French fries to coffee. The highest levels are in fried and baked products such as potato chips and other snack foods. Although classified as a probable human carcinogen on the basis of animal studies, there is currently no consensus on dietary acrylamide's risks to human health. With food safety authorities in Europe taking steps to curb acrylamide, controversy has arisen over whether similar action should be taken in the U. S.

In a previous study among Swedish women, Mucci and colleagues found no association between dietary acrylamide and cancer risk. Now those findings have been extended to women in the United States. In the new study, researchers followed the a group of 100,000 U.S. nurses over 20 years (from 1980 to 2000) via periodic questionnaires about their dietary habits, including the type of foods eaten and their frequency of consumption. Researchers used the data to estimate daily acrylamide intake, while collecting information on the incidence of breast cancer among the women.

They identified over 3000 cases of breast cancer. The incidence of breast cancer among women with high acrylamide intake was about the same as that among women with low intakes, indicating a lack of association between acrylamide intake and breast cancer, the researchers say.

The lack of association between acrylamide and breast cancer was evident across both the U.S. and Swedish study populations despite divergent diets among the two groups, Mucci says. Among U.S. women, the largest source of dietary acrylamide is French fries, while in the Swedish women, the largest source is coffee. Mucci added, "Although we found no significant association between acrylamide in the diet and increased risk for breast cancer among the study participants, it is quite important to stress the importance of eating a healthy diet that includes foods low in saturated and trans fats, unlike French fries and potato chips."

Mucci cited several possible explanations for the different findings in animals and humans. Animals, for instance, were exposed to acrylamide levels 1000 to 100,000 times higher than found in the human diet. In addition, humans may detoxify acrylamide at levels found in the diet, she says.

"The story of dietary acrylamide and cancer risk in humans is still emerging, and additional epidemiological studies examining other cancers and in additional populations are warranted, including biomarker assessment of acrylamide exposure," says Mucci. She does not rule out the possibility that dietary acrylamide can cause other health problems, but only breast cancer was explored in the current study, which was funded by the National Institutes of Health.

Mucci and her associates are currently conducting an epidemiological study among a group of 3,000 men in Sweden to explore a possible link between acrylamide in foods and risk of prostate cancer. The new study will also examine blood biomarkers of acrylamide, as well as estimates from dietary questionnaires.

Their presentation highlights a symposium that includes 40 papers that explore possible mechanisms by which acrylamide could cause cancer, new food preparation techniques to limit its formation and other topics discussed in a related tipsheet.
The American Chemical Society -- the world's largest scientific society -- is a nonprofit organization chartered by the U.S. Congress and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.

-- Mark T. Sampson

Note for reporters' use only: For full information about the Boston meeting, including access to abstracts of more than 9,500 scientific papers and hundreds of non-technical summaries, visit News release images are available at

The paper on this research, AGFD 082, will be presented at 11:35 a.m., Tuesday, Aug. 21, at the Boston Convention & Exhibition Center, Room 256, during the symposium, "Chemistry and Toxicology of Acrylamide."

Lorelei Mucci, ScD, is an epidemiologist at Channing Labs at Brigham and Women's Hospital and Harvard School of Public Health in Boston.

American Chemical Society

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to